SCHEMBL5042430

SCHEMBL5042430

Cc1ccc(S(=O)(=O)[O-])cc1.O=c1c2ccccc2oc2c([S+](c3ccccc3)c3ccccc3)cccc12

nearest known ligand 0.43

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.43
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 6/20 0.43
LMNA P02545 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TTR P02766 1/20 0.39
HTT P42858 2/20 0.39
TP53 P04637 2/20 0.39
TSHR P16473 2/20 0.39
RET P07949 1/20 0.39
ALOX12 P18054 1/20 0.39
KDR P35968 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GLA P06280 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
PGAM1 P18669 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3523127 0.87 RXFP1 (0.36) KDM4EALDH1A1LMNAHTTTP53
Trifluoromethanesulfonic Acid SCHEMBL3520068 0.83 MAOA (0.48) MAOAKDM4EALDH1A1LMNANPC1
SCHEMBL3517596 0.82 CYP2A6 (0.38) KDM4EALDH1A1LMNASMN1; SMN2GLA
SCHEMBL3519753 0.81 NPC1 (0.45) MAOAKDM4EALDH1A1LMNANPC1
SCHEMBL3521324 0.80 MAOA (0.49) MAOAKDM4EALDH1A1LMNANPC1
SCHEMBL3520947 0.79 NPC1 (0.47) MAOAKDM4EALDH1A1LMNANPC1
SCHEMBL3517033 0.78 MAOA (0.40) MAOAKDM4EALDH1A1LMNANPC1
SCHEMBL3137506 0.77 HKDC1 (0.41) ALDH1A1LMNAHTTSMN1; SMN2CYP3A4
SCHEMBL3127290 0.74 CA12 (0.40) KDM4EALDH1A1LMNAHTTALOX12
SCHEMBL3520322 0.73 TTR (0.47) MAOAKDM4EALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481973-B1 HETEROCYCLE-BEARING ONIUM SALTS WAKO PURE CHEM IND LTD (JP) 2008-12-31 EP disclosed
EP-1953149-A2 A heterocycle-containing onium salt Wako Pure Chemical Industries, Ltd. (JP) 2008-08-06 EP disclosed
US-7318991-B2 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-15 US disclosed
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) 2005-10-20 US disclosed
EP-1481973-A1 HETEROCYCLE-BEARING ONIUM SALTS Wako Pure Chemical Industries, Ltd. (JP) 2004-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether NOX4, CBR1, CBR3 MAOA 1663/4885KDM4E 2670/4885ALDH1A1 1190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.